Back

Increased serum PRO-C3 is associated with heart failure worsening in hypertensive patients with heart failure

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - biomarkers 2 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Inigo Latasa Amezqueta

Center for Applied Medical Research, Pamplona (Spain)

6 More presentations in this session

Presentation thumbnail
Fibrosis-4 index may predict long-term mortality in patients admitted for acute decompensated heart failure
Associate Professor B. MURAT (Eskisehir, TR)
Abstract Slides Video
Presentation thumbnail
Proteomic profiles of left atrial volume and its influence on response to spironolactone: findings from the HOMAGE trial and STANISLAS cohort
Doctor M. Kobayashi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Circulating levels of erythrocytes-derived vesicles related to poor glycaemia control in heart failure patients with type 2 diabetes mellitus
Professor A. Berezin (Salzburg, AT)
Abstract Slides Video
Presentation thumbnail
Normal troponin T and NTproBNP values effectively rule-out cardiac amyloidosis in patients with prior bilateral surgery for carpal tunnel syndrome.
Doctor N. Noory (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Pro-adrenomedullin may guide decongestive therapy in acute heart failure patients
Doctor B. Beer (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - biomarkers 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure
thumbnail
Congress Presentation
Differences in the optimization of pharmacological treatment in patients with heart failure and reduced ejection fraction and advanced chronic kidney disease.
thumbnail
Congress Presentation
Congestion as a crucial factor determining albuminuria in in patients with cardiorenal disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources